The death of cost‐minimization analysis? [PDF]
Health Economics, 2001 AbstractFour different types of evaluation methods, cost‐benefit analysis (CBA), cost‐utility analysis (CUA), cost‐effectiveness analysis (CEA) and cost‐minimization analysis (CMA), are usually distinguished. In this note, we pronounce the (near) death of CMA by showing the rare circumstances under which CMA is an appropriate method of analysis.
Briggs, A.H., O'Brien, B.J.
core +7 more sources
Counting the Cost of Daptomycin Versus Vancomycin in Hospitalized Patients: A Cost Minimization Analysis. [PDF]
Open Forum Infect DisAbstract Daptomycin use for gram-positive infections has increased. This cost minimization analysis aimed to determine cost and/or time savings of daptomycin over vancomycin. The estimated hospital cost savings was US$166.41 per patient, and pharmacist time saved of almost 20 minutes per patient. Daptomycin has the potential to save both
Wagner JL +7 more
europepmc +4 more sources
Analysis of an information-theoretic model for communication [PDF]
J. Stat. Mech. (2012) P12022, 2012 We study the cost-minimization problem posed by Ferrer i Cancho and Sol\'e in their model of communication that aimed at explaining the origin of Zipf's law [PNAS 100, 788 (2003)]. Direct analysis shows that the minimum cost is $\min {\lambda, 1-\lambda}$, where $\lambda$ determines the relative weights of speaker's and hearer's costs in the total, as ...
Altmann, Eduardo G. +2 more
arxiv +3 more sources
Resources Utilization Assessment and Cost-Minimization Analysis of the 6-Monthly Formulation of Triptorelin in the Treatment of Prostate Cancer in China. [PDF]
Clinicoecon Outcomes ResYing Chen,1 Jiahua Pan,2 Yan Zhong,3 Bin Wu,1 Mengxia Yan,4 Ruiyun Zhang2 1Clinical Research Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200000, People’s Republic of China; 2Department of Urology, Renji Hospital,
Chen Y +5 more
europepmc +2 more sources
Real-World Six-Year National Cost-Minimization Analysis of IncobotulinumtoxinA and OnabotulinumtoxinA in the VA/DoD Healthcare Systems. [PDF]
Clinicoecon Outcomes Res, 2021 Rashid Kazerooni, 1 Ileana M Howard, 2, 3 Adrienne M Keener, 4, 5 Mark Bounthavong 6, 7 1Merz Pharmaceuticals, LLC, Raleigh, NC, 27615, USA; 2Rehabilitation Care Services, VA Puget Sound, Seattle, WA, USA; 3Department of Rehabilitation Medicine ...
Kazerooni R +3 more
europepmc +2 more sources
Economic implications of step-down outpatient management for fever and neutropenia episodes in pediatric cancer patients: a cost minimization analysis. [PDF]
BMC Health Serv ResBackground The management of febrile neutropenia (FN) in pediatric cancer patients has traditionally been conducted in a hospital setting. However, recent evidence has indicated that outpatient management of FN can be equally effective compared to ...
Avilés-Robles MJ, Reyes-López A.
europepmc +2 more sources
Cost Minimization Analysis of a Running Firm with Economic Policy
Annals of Spiru Haret University. Economic Series, 2022 In this paper the Cobb-Douglas production function is operated in a firm for the analysis of the cost minimization policies. In an economic world, gain of profit depends on the efficient use of raw materials and use of various techniques of the cost minimization. A firm’s main target is to make maximum profit. Scientific based and efficient but minimum
H. Mohajan
openaire +3 more sources
ClinicoEconomics and Outcomes Research, 2020 Jyoti Aggarwal,1 Jacqueline Lustrino,1 Jennifer Stephens,2 Diana Morgenstern,3 Wing Yu Tang4 1Pharmerit International, Newton, MA, USA; 2Pharmerit International, Bethesda, MD, USA; 3Pfizer, Collegeville, PA, USA; 4Pfizer, New York, NY, USACorrespondence:
Aggarwal J +4 more
doaj +2 more sources
Cost minimization analysis of BoNT-As in the treatment of upper limb spasticity and cervical dystonia [PDF]
, 2016 Botulinum toxin type A (BoNT-A) injections are recommended for the management of upper limb spasticity (ULS) and cervical dystonia (CD). The main aim of this cost minimization analysis (CMA) was to compare the annual cost per patient for three BoNT-As ...
Luigi Bartolomei +15 more
openalex +4 more sources
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma. [PDF]
Front Oncol, 2021 BackgroundMalignant pleural mesothelioma (MPM) is rare and aggressive neoplasia, with a poor prognosis; furthermore, the monetary cost of its treatment represents a major challenge for many patients.
Arrieta O +13 more
europepmc +2 more sources